Breast Cancer

Genetics company identifies novel genetic risk markers for breast cancer

Published in Cancer Weekly, November 18th, 2003

Sequenom, Inc., (SQNM) has identified novel genetic markers in four genes for susceptibility to breast cancer.

Each gene has forms that increase or decrease the risk for developing breast tumors. The company's data indicate common combinations of its proprietary breast cancer markers increase the average risk of developing breast cancer by a factor of two, present in approximately 11% of the female population.

Certain rare combinations are estimated to increase the disease risk by up to a factor of five. The protective forms of the genes are present in approximately 13% of the female population and are associated with a fivefold decreased risk of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2003-11-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry